Coroner warns people may not realise severity of burn injuries after death of Cavan farmer (79)
A coroner has warned that people may not realise the severity of burn injuries in some cases, after hearing about the death of an elderly Cavan man after a stick fell out of a wood-burning stove in his home.
Patrick Lynch (79), a retired farmer of Cormore, Arva, Co Cavan, died as a result of complications of burn injuries at St James's Hospital in Dublin on August 29th, 2023.
Advertisement
A sitting of Dublin District Coroner's Court heard a neighbour of Mr Lynch had discovered a smouldering stick in a smoke-filled room when he called to see the deceased around 1:15pm on August 26th, 2023.
Ciaran Ellis told an inquest into Mr Lynch's death that he rang an ambulance after discovering his neighbour lying crossways on a bed with his feet 'red with burns.'
Mr Ellis said a stick that seemed to have fallen out of a door at the front of the stove was still smouldering on the floor.
He recalled that the deceased's pyjamas and part of a chair were also burnt, although there was no evidence of a large fire of any type.
Advertisement
When asked how he felt, Mr Ellis said Mr Lynch had replied that he was not in any pain.
'He did not realise he was badly burnt,' said Mr Ellis.
He said the deceased only complained about feeling a little bit of pain a few hours later, just before an ambulance arrived at around 4:30pm.
The coroner, Cróna Gallagher, said some people with burn injuries did not appreciate the severity of their burns as they did not feel any pain because the injuries were so bad that nerve endings in their body had been damaged.
Advertisement
'People with less severe burn injuries may feel far worse pain,' said Dr Gallagher.
She observed that people with severe burn injuries might not seek the urgent treatment that they needed due to the misconception that the lack of pain indicated they were not badly hurt.
'It's a common issue that the part that is burnt can just look red, which means people think it might not be serious,' said Dr Gallagher.
In reply to questions from the coroner, Mr Ellis said he would check on his neighbour two to three times per day.
Advertisement
He explained the deceased had moved his bedroom downstairs to the living room a few years previously because of his mobility issues.
Mr Ellis also said his neighbour used the stove as his main source of heating and would be in the habit of packing it with wood.
The deceased's brother, Jimmy Lynch, who gave evidence of formally identifying his brother's body to gardaí at St James's Hospital, said his brother had lived alone for over 25 years.
While the deceased had a few health problems, including poor eyesight, Mr Lynch said his brother was able to manage, although he had not really left his house for a number of years.
Advertisement
Mr Lynch said he was never aware of any problem that his brother, who was a non-smoker, had with the stove.
Sergeant Cathal Buggy gave evidence of examining the scene of the fatal incident and being satisfied that there was nothing suspicious about what happened.
Sgt Buggy also confirmed that there was nothing defective with the stove.
In a written statement, a paramedic, Billy Bushnell, said the initial triaging from the call for assistance had assessed Mr Lynch as a 'low priority' case.
Mr Bushnell said the injured man was chatty and responsive to paramedics after the ambulance arrived at his house at 4:28pm.
He said Mr Lynch had some third-degree burns and massive blistering on his legs, although he had stated that the pain was 'not too bad.'
Mr Bushnell said he advised his controllers that the patient should be brought to St James's Hospital in Dublin, where the National Burns Unit is based, but was instructed to take him to Cavan General Hospital.
He said he phoned ahead to the hospital in Cavan to have a resus team on standby, but none was in place by the time they arrived.
The inquest heard Mr Lynch was transferred to St James's Hospital the following morning.
Medical records showed he suffered burns to approximately 30 per cent of his body, which mostly related to his lower limbs.
Doctors in St James's assessed him as requiring immediate surgery for full-thickness burns, as it was a life-threatening situation.
However, they subsequently assessed that he would not survive further surgery, and his treatment was switched to palliative care.
Dr Gallagher observed that it was not clear if it would have made any difference if Mr Lynch had received treatment sooner, although she believed it was 'unlikely".
The results of a postmortem showed he had died as a result of complications of burns from material from a wood-burning stove, with heart disease as a contributory factor.
Offering her sympathy to Mr Lynch's relatives, the coroner recorded a verdict of accidental death.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
36 minutes ago
- The Independent
Weight loss jab could be used to treat migraines
Weight loss jabs could cut the number of migraines sufferers experience by half, research suggests. The drugs, similar to Ozempic and Wegovy, also known as GLP-1 receptor agonists, work by mimicking the natural hormone which regulates blood sugar, appetite and digestion. Researchers have discovered, GLP-1 drug liraglutide, commonly used to treat diabetes, has the potential to significantly reduce migraine frequency. Migraines affect approximately 6 million people in the UK, according to the NHS. Attacks can last for three days causing pain, nausea, vomiting, dizziness and sensitivity to light, sound and smells. Researchers at the Headache Centre of the University of Naples gave 26 adults with obesity and chronic migraines the drug liraglutide. The study presented at the European Academy of Neurology (EAN) Congress 2025, found those who had the drug reported an average of 11 fewer headache days per month. Participants also experienced meaningful improvements in quality of life, work, study, and social functioning within just two weeks of taking the drug. 'Most patients felt better within the first two weeks and reported quality of life improved significantly', said lead researcher Dr Simone Braca. 'The benefit lasted for the full three-month observation period, even though weight loss was modest and statistically non-significant.' Growing evidence has linked subtle increases in intracranial pressure to migraine attacks. It's caused by a rise in the pressure of cerebrospinal fluid – which surrounds the brain and spinal cord. This increase in pressure can happen because of a severe head injury, stroke, a brain tumour or high blood pressure. But GLP-1-receptor agonists such as liraglutide reduce cerebrospinal fluid secretion and have already proved effective in treating idiopathic intracranial hypertension (IIH). Patients in the study were screened to exclude papilledema (optic disc swelling resulting from increased intracranial pressure) and sixth nerve palsy, ruling out IIH. Dr Braca and colleagues believe GLP-1 drugs may reduce the release of CGRP (calcitonin gene-related peptide), a key molecule behind migraines. 'We think that, by modulating cerebrospinal fluid pressure and reducing intracranial venous sinuses compression, these drugs produce a decrease in the release of calcitonin gene-related peptide (CGRP), a key migraine-promoting peptide', Dr Braca said. 'That would pose intracranial pressure control as a brand-new, pharmacologically targetable pathway.' Given liraglutide's established use in type 2 diabetes and obesity, it may represent a promising case of drug repurposing in neurology, study authors said.
The Independent
36 minutes ago
- The Independent
Popular children's cough medicine recalled over potentially deadly bacterial infection risk
A popular cough medicine for children has been recalled over a risk of bacterial infection that can be deadly. Little Remedies Honey Cough Syrup was recalled Tuesday over the 'presence' of Bacillus cereus, a type of bacteria that can cause two types of foodborne illnesses, and because of 'loss of shelf-stability,' according to a notice from the medicine makers, Medtech Products Inc. The recall describes the symptoms associated with both foodborne illnesses. One can cause nausea, vomiting and stomach cramps starting one to six hours after consuming contaminated food. The second illness can cause stomach cramps and diarrhea starting 8 to 16 hours after exposure. 'Although healthy individuals may suffer only short-term illness, exposure to high levels of foodborne B. cereus can cause death,' the recall notice warned. No serious adverse effects have been reported as of the date of the recall. The recalled cough syrup was sold by retailers throughout the country and online from December 14, 2022, to June 4, 2025. Consumers with the recalled medicine are advised to stop using it immediately and contact their doctor if they experience any symptoms that may be related to the product. The company is also offering a refund of the product.
The Guardian
an hour ago
- The Guardian
All babies in England to get DNA test to assess risk of diseases within 10 years
Every baby in England is to have a DNA screening to avoid fatal diseases and receive personalised healthcare as part of the government's £650m investment in DNA technology, it has been reported. Within a decade, every newborn will undergo whole genome sequencing, which assesses the risk of hundreds of diseases and is expected to form part of the government's 10-year plan for the health service. Wes Streeting, the health secretary, told the Telegraph the advances in genomics would allow people to 'leapfrog' killer illnesses and receive 'personalised' health care. He said: 'The revolution in medical science means that we can transform the NHS over the coming decade, from a service which diagnoses and treats ill health to one that predicts and prevents it. 'Genomics presents us with the opportunity to leapfrog disease, so we're in front of it rather than reacting to it.' Streeting added: 'With the power of this new technology, patients will be able to receive personalised healthcare to prevent ill health before symptoms begin, reducing the pressure on NHS services and helping people live longer, healthier lives.' All new parents are now offered a blood spot test for their babies, normally when the child is five days old, to check whether they have any of nine rare but serious conditions. The newborn's heel is pricked to collect a few drops of blood on a card that is sent away to be tested. Along with a greater focus on prevention, the 10-year plan is expected to include Streeting's other 'shifts' in the NHS, from hospitals towards more community-focused care and from analogue to digital services. Last week the chancellor, Rachel Reeves, announced that the government would increase NHS funding by £29bn a year in real terms over the next three years. A Department of Health and Social Care spokesperson said: 'Our 10-year health plan will be published soon and will set out details for a range of initiatives to advance the NHS and make it fit for the future.' In October, the NHS in England announced it was to screen 100,000 newborn babies for more than 200 genetic conditions in a world-first scheme aimed at bolstering early diagnosis and treatment.
